Organization · Venture Capital
AIHF
AIHF, or AI Health Fund, is an early-stage venture fund focused on investing in artificial intelligence companies that enhance health outcomes. It operates in the United States, particularly within the Stanford-adjacent ecosystem.
Overview
What AIHF does
What AIHF is
AIHF, or AI Health Fund, is an early-stage venture fund focused on investing in artificial intelligence companies that enhance health outcomes. It operates in the United States, particularly within the Stanford-adjacent ecosystem.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2026
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find AIHF elsewhere
Open the official website or a supported primary organization account.
Capability profile
AIHF as a funder
Investment thesis
AIHF invests in companies fixing health with computational solutions that make patients healthier, treatment better, and health systems stronger.
Focus narrative
AIHF focuses on early-stage investments in AI and healthcare, specifically targeting computational solutions that enhance health outcomes. The fund supports founders through the Treehub residency, which emphasizes product-market fit and company direction, ultimately preparing them for larger funding rounds or integration into healthcare systems.
Value beyond capital
AIHF provides not only capital but also operational support and company-building assistance to founders, particularly those from academic backgrounds. The residency model offers structured guidance through the early stages of company development, helping founders navigate the complexities of launching AI-driven health solutions.
Terms and economics
- Typical check
- $50,000–$150,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include Clair Health, a women's hormone tracker that also participated in a16z Speedrun, and a pediatric autism company from researcher Dennis Wall. AIHF has backed 12 companies from the Treehub program as of April 2026.
Common questions
What to know about AIHF
Upseed classifies AIHF under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.